Invention Application
- Patent Title: MODULATION OF NLGn4 EXPRESSION, NK CELL ACTIVITY IN NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD)
-
Application No.: US15914112Application Date: 2018-03-07
-
Publication No.: US20180202001A1Publication Date: 2018-07-19
- Inventor: Rifaat SAFADI
- Applicant: HADASIT MEDICAL RESEARCH SERVICES AND DEVELOPMENT LTD.
- Main IPC: C12Q1/6883
- IPC: C12Q1/6883 ; A61K31/713 ; A61K31/7105 ; C12N15/113 ; A61K45/06 ; A61K31/7088
Abstract:
A kit having a means for isolating an immune cell population from a biological sample of a patient; and at least one agent capable of detecting NLGn4 gene product expression level.
Public/Granted literature
- US10266897B2 Modulation of NLGn4 expression, NK cell activity in non-alcoholic fatty liver disease (NAFLD) Public/Granted day:2019-04-23
Information query
